These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 14183048)
1. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS. BRODSKY I; ROSS E; REID WO Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048 [No Abstract] [Full Text] [Related]
2. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS. SWEENEY WM Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294 [No Abstract] [Full Text] [Related]
3. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS]. WEISS M; YVER J; SAMAMA M; DUBOST C Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607 [No Abstract] [Full Text] [Related]
4. USE OF EPSILON AMINOCAPROIC ACID. GANS H Surg Gynecol Obstet; 1965 Mar; 120():576-7. PubMed ID: 14262059 [No Abstract] [Full Text] [Related]
6. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME]. GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937 [No Abstract] [Full Text] [Related]
7. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS]. VAIREL E; LANDE M; LEGER L Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753 [No Abstract] [Full Text] [Related]
8. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS]. OPPELT HG; BECK L Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686 [No Abstract] [Full Text] [Related]
9. EFFECTS OF EPSILON AMINOCAPROIC ACID ON COAGULATION AND FIBRINOLYTIC MECHANISMS. LEWIS JH; DOYLE AP JAMA; 1964 Apr; 188():56-63. PubMed ID: 14107215 [No Abstract] [Full Text] [Related]
12. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS. MCNICOL GP; DOUGLAS AS Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764 [No Abstract] [Full Text] [Related]
13. ANTIFIBRINOLYTIC TREATMENT WITH EPSILON-AMINOCAPROIC ACID IN CONNECTION WITH PROSTATECTOMY. ANDERSSON L Acta Chir Scand; 1964 May; 127():552-64. PubMed ID: 14169785 [No Abstract] [Full Text] [Related]
14. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS]. CASTILLO R; SERRANO J; CARALPS A; VINAS M Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259 [No Abstract] [Full Text] [Related]
15. 2 CASES OF FIBRINOLYSIS DURING SHUNT OPERATION IN CIRRHOSIS OF THE LIVER. LEIBA H; RAMOT B; MANY A Isr Med J; 1964; 23():176-80. PubMed ID: 14215370 [No Abstract] [Full Text] [Related]
17. [UTILIZATION OF EPSILON-AMINOCAPROIC ACID IN HEMORRHAGE FROM THROMBOPATHY IN AN ANURIC PATIENT]. NICOLAS F; GUIMBRETIERE J Anesth Analg (Paris); 1965; 22():139-47. PubMed ID: 14283360 [No Abstract] [Full Text] [Related]
18. [FIBRINOLYSIS; CLINICAL APPLICATIONS]. BOSMAN G Folia Med Neerl; 1964 Dec; 7():178-83. PubMed ID: 14265806 [No Abstract] [Full Text] [Related]
19. PATHOLOGICAL FIBRINOLYSIS. SHARP AA Br Med Bull; 1964 Sep; 20():240-6. PubMed ID: 14216086 [No Abstract] [Full Text] [Related]